Abstract
With advancing age the large arteries of the body become more stiff and less compliant, which causes an increase in systolic blood pressure and pulse pressure as well as a decrease in diastolic blood pressure. A perusal of the literature reveals that in the last few years there is ample evidence and multiple publications claiming that a wide pulse pressure, reflecting large artery stiffness, is a significant and at times independent risk factor for cardiovascular disease particularly in the elderly. This article presents a review and a summary of the salient studies and trials conducted in different institutions and countries correlating the increase in pulse pressure with cardiovascular outcomes primarily cardiovascular mortality, coronary artery disease, myocardial infarction, congestive heart failure and stroke. The information available, although mainly consistent, is insufficient to determine if the encountered relationship of wide pulse pressure and cardiovascular events is causal or whether wide pulse pressure is just a marker of an underlying disease. There has been no trial to test the benefit of treating wide pulse pressure. In order to decide if pulse pressure will become clinically useful for the definition and management of hypertension and for cardiovascular risk stratification we will need more research and randomized clinical trials to explore if reversal in coronary risk and cardiovascular complications is obtained with drugs that decrease pulse pressure and if pulse pressure monitoring will be useful for coronary risk stratification.
Keywords: wide pulse pressure, arterial stiffness, cardiovascular mortality, heart failure, myocardial infarction, stroke
Current Cardiology Reviews
Title: Wide Pulse Pressure in the Elderly
Volume: 1 Issue: 3
Author(s): Mario R. Garcia-Palmieri
Affiliation:
Keywords: wide pulse pressure, arterial stiffness, cardiovascular mortality, heart failure, myocardial infarction, stroke
Abstract: With advancing age the large arteries of the body become more stiff and less compliant, which causes an increase in systolic blood pressure and pulse pressure as well as a decrease in diastolic blood pressure. A perusal of the literature reveals that in the last few years there is ample evidence and multiple publications claiming that a wide pulse pressure, reflecting large artery stiffness, is a significant and at times independent risk factor for cardiovascular disease particularly in the elderly. This article presents a review and a summary of the salient studies and trials conducted in different institutions and countries correlating the increase in pulse pressure with cardiovascular outcomes primarily cardiovascular mortality, coronary artery disease, myocardial infarction, congestive heart failure and stroke. The information available, although mainly consistent, is insufficient to determine if the encountered relationship of wide pulse pressure and cardiovascular events is causal or whether wide pulse pressure is just a marker of an underlying disease. There has been no trial to test the benefit of treating wide pulse pressure. In order to decide if pulse pressure will become clinically useful for the definition and management of hypertension and for cardiovascular risk stratification we will need more research and randomized clinical trials to explore if reversal in coronary risk and cardiovascular complications is obtained with drugs that decrease pulse pressure and if pulse pressure monitoring will be useful for coronary risk stratification.
Export Options
About this article
Cite this article as:
Garcia-Palmieri R. Mario, Wide Pulse Pressure in the Elderly, Current Cardiology Reviews 2005; 1 (3) . https://dx.doi.org/10.2174/157340305774574170
DOI https://dx.doi.org/10.2174/157340305774574170 |
Print ISSN 1573-403X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6557 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Relevance of Postprandial Lipemia in Metabolic Syndrome
Current Vascular Pharmacology Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan
Current Drug Delivery Pharmacological Treatments for Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Synthesis and Investigating Hypoglycemic and Hypolipidemic Activities of Some Glibenclamide Analogues in Rats
Mini-Reviews in Medicinal Chemistry Editorial (Thematic Issue: Myokines and Exercise Training: More Shadows than Lights)
Current Pharmaceutical Design Substance Abuse and Movement Disorders
Current Drug Abuse Reviews Preparation and Evaluation of ‘3 Cap’ Pulsatile Drug Delivery System of Ramipril
Cardiovascular & Hematological Agents in Medicinal Chemistry Association of Thrombospondin-1 (N700S) and Thrombospond in-4 (A387P) Gene Polymorphisms with the Incidence of Acute Myocardial Infarction in Egyptians
Current Pharmaceutical Biotechnology Impaired Neural Transmission and Synaptic Plasticity in Superior Cervical Ganglia from β-Amyloid Rat Model of Alzheimers Disease
Current Alzheimer Research Synthesis and Biological Activity of 3-(2, 8, 9-Trioxa-aza-1-germatricyclo [3. 3. 3. 0]undecane-1-yl)-hydroxycinnamic Acids
Medicinal Chemistry Pharmacologic Treatment of Pulmonary Arterial Hypertension
Current Pharmaceutical Design Recent Developments in the Synthesis of Cinnoline Derivatives
Mini-Reviews in Organic Chemistry The Acquired Deficiency of C1-Inhibitor: Lymphoproliferation and Angioedema
Current Molecular Medicine Diltiazem Analogues: The Last Ten Years on Structure Activity Relationships
Current Medicinal Chemistry Withdrawal Notice: Reconnoitering the Role of Endothelin in Obesity
Current Pharmaceutical Design Hot Melt Extruded and Injection Moulded Dosage Forms: Recent Research and Patents
Recent Patents on Drug Delivery & Formulation Targeting TRP Channels in Airway Disorders
Current Topics in Medicinal Chemistry Aliskiren: A New Drug for an Old Problem
Cardiovascular & Hematological Agents in Medicinal Chemistry Current Pharmacologic Management of Pediatric Heart Failure in Congenital Heart Disease
Current Vascular Pharmacology Aging Blunts Ischemic-Preconditioning-Induced Neuroprotection Following Transient Global Ischemia in Rats
Current Neurovascular Research